Effects by 8-bromo-cyclicAMP on basal and organic dust-induced release of interleukin-6 and interleukin-8 in A549 human airway epithelial cells

Received 9 January 2002; accepted 27 May 2002.

Abstract

Inhalation of organic dust from a swine-confinement building leads to an intense inflammatory reaction with an increased number of inflammatory cells and mediators in the upper and lower respiratory tract of previously unexposed subjects. In vitro the dust induces cytokine release from epithelial cells and alveolar macrophages. It is known that intracellular cyclic AMP (cAMP) contributes to the regulation of inflammatory responses. We therefore investigated whether 8-Bromo-cAMP, a cell membrane-permeable cAMP analogue, would influence release of the cytokines interleukin-6 (IL-6) and IL-8 in a human airway epithelial cell line, A549, exposed to a suspension of the organic dust, and to a supernatant prepared by centrifugation (at low g-force) of a suspension of dust. The large particulate matter was thus sedimented, leaving bacteria, whole and cell wall constituents in the supernatant. Cytokine release was measured with enzyme-linked immunosorbent assay (ELISA). The cytokine release induced by a supernatant was 23% (IL-6) and 27% (IL-8) of the release induced by a dust suspension. 8-Bromo-cAMP (1mM) doubled basal IL-6 release and IL-6 release induced by a dust supernatant (P<0.01), and increased IL-6 release induced by a dust suspension by 19% (P<0.05). 8-Bromo-cAMP did not affect basal IL-8 release, partially inhibited (28%) the release of IL-8 induced by a dust suspension (P<0.01), but increased IL-8 release induced by a dust supernatant by 13% (P<0.05). In summary, expression of the cytokines IL-6 and IL-8 is differentially regulated by 8-Bromo-cAMP, both with regard to basal and dust-induced release. The results indicate that 8-Bromo-cAMP attenuated IL-8 release by affecting signaling transductions induced by the particulate fraction.

Keywords: airway epithelial cells, A549, 8-Bromo-cAMP, cytokine release, organic dust, particles.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

REFERENCES

1. 1 Larsson K, Eklund A, Hansson L-O, Isaksson B-M, Malmberg P. Swine dust causes intense airways inflammation in healthy subjects. Am J Crit Care Med. 1994;150:973–977.

2. 2 Wang Z, Larsson K, Palmberg L, Malmberg P, Larsson P, Larsson L. Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J. 1997;10:381–387. MEDLINE | CrossRef

3. 3 Palmberg L, Larsson B-M, Malmberg P, Larsson K. Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax. 1998;53:260–264. MEDLINE | CrossRef

4. 4 Wang Z, Malmberg P, Ek A, Larsson K, Palmberg L. Swine dust induces cytokine secretion from human epithelial cells and alveolar macrophages. Clin Exp Immunol. 1999;115:6–12. MEDLINE | CrossRef

5. 5 Sandström T, Bjermer L, Rylander R. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respir J. 1992;5:992–996. MEDLINE

6. 6 Wang Z, Malmberg P, Larsson B-M, Larsson K, Larsson L, Saraf A. Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med. 1996;154:1261–1266.

7. 7 Zhang H, Kim Y, Govindarajan A. Effect of adrenoceptors on endotoxin-induced cytokines and lipid peroxidation in lung explant. Am J Respir Crit Care Med. 1999;160:1703–1710.

8. 8 Hallsworth M, Twort C, Lee T, Hirst S. β2-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol. 2001;132:729–741. MEDLINE | CrossRef

9. 9 Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Viewpoint Immuno Today. 1997;18:428–432.

10. 10 Xing Z, Gauldie J, Cox G. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311–320. MEDLINE | CrossRef

11. 11 Keller TK, Wanagat J, Ershler W. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci. 1996;1:340–357.

12. 12 Ben–Baruch A, Michiel DF, Oppenheim J. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem. 1995;270:11703–11706. MEDLINE | CrossRef

13. 13 Leiber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continous tumor cell line from human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17:62–70. MEDLINE | CrossRef

14. 14 Ek A, Larsson K, Siljerud S, Palmberg L. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy. 1999;54:691–699.

15. 15 Fuhrmann M, Jahn H-U, Seybold J. Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol. 1999;20:292–302. MEDLINE

16. 16 Linden A. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol. 1996;119:402–406. MEDLINE

17. 17 Holtmann H, Winzen R, Holland P. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol. 1999;19:6742–6753. MEDLINE

18. 18 Zidek Z. Adenosine-cyclicAMP pathways and cytokine expression. Eur Cytokine Network. 1999;10:319–328.

19. 19 Sitaraman S, Merlin D, Wang L. Neutrophil-epithelial crosstalk at the interstitial lumenal surface mediated by reciprocal secretion of adenosin and IL-6. J Clin Invest. 2001;107:861–869. MEDLINE | CrossRef

20. 20 Haddad JJ, Land S, Tarnow-Mordi W. Immunopharmacological potential of selective phosphodiesterase inhibition. J Pharmacol Exp Ther. 2002;300:559–566. MEDLINE | CrossRef

21. 21 Lien E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002;30:S1–S11. MEDLINE | CrossRef

22. 22 Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med. 2002;195:559–570. MEDLINE | CrossRef

23. 23 Smirnova I, Poltorak A, Chan E, McBride C, Beutler B. Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol. 2000;1:1–10.

a National Institute for Working Life, Stockholm, Sweden

b The National Institute of Environmental Medicine, Lung- and Allergy Research, Karolinska Institute, Stockholm, Sweden

f1 Correspondence should be addressed to: Dr Lena, Palmberg, MD, Ph D, The National Institute of Environmental Medicine, Lung- and Allergy Research, Karolinska Institute, SE-171 77 Stockholm, Sweden. E-mail:lena.palmberg@imm.ki.se

PII: S0954-6111(02)91415-0

doi:10.1053/rmed.2002.1415

8 of 18